SaschaNiluGoonewardenaMD
Cardiology • Ann Arbor, MIAdult Congenital Heart Disease
Assistant Professor of Medicine
Dr. Goonewardena is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-8214Fax+1 734-647-0387- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Cardiovascular Disease, 2007 - 2011
University of ChicagoResidency, Internal Medicine, 2003 - 2006
University of Michigan Medical SchoolClass of 2003
Certifications & Licensure
MI State Medical License 2007 - 2026
IL State Medical License 2003 - 2008- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects.Ashley Tate, Phyu Mar, Olga Grushko, Qinzhong Chen, Robert S Rosenson, Sascha N Goonewardena> ;Atherosclerosis. 2024 Mar 25
- Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19.Qinzhong Chen, Ashley M Tate, Olga G Grushko, Dilna Damodaran, Pennelope Blakely, Sascha N Goonewardena, Salim S Hayek, David J Pinsky, Robert S Rosenson> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2024 Mar 21
- The Impact of Social Determinants of Health and Lifestyle on the Association of Lipoprotein(a) with Myocardial Infarction and Stroke.Eric J Brandt, Matthias Kirch, Nimai Patel, Chaitanya Chennareddy, Venkatesh L Murthy, Sascha N Goonewardena> ;Medrxiv. 2023 Sep 3
- Join now to see all
Press Mentions
First-in-Human Trial for Oral Drug to Remove Radioactive ContaminantsMay 15th, 2023- First-in-Human Trial of Oral Drug to Remove Radioactive Contamination BeginsMay 15th, 2023
- PCSK9 Inhibitors for Severe COVID? Pilot Trial Signals of BenefitJanuary 20th, 2023
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Michigan Medical CenterAnn Arbor, Michigan
Veterans Affairs Ann Arbor Healthcare SystemAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
